Cell-mediated Immunity

DBCAT004059Pharmacologic class

A DrugBank category of 623 drugs. 617 of them are approved.

Drugs: 2-mercaptobenzothiazole
2,2'-Dibenzothiazyl disulfide
4-(Isopropylamino)diphenylamine
Acacia
Acacia baileyana pollen
Acacia dealbata pollen
Acacia longifolia pollen
Acacia pollen
Acer macrophyllum pollen
Acer negundo pollen
Acer rubrum pollen
Acer saccharinum pollen
Acer saccharum pollen
Acheta domesticus
Acrothecium robustum
Aedes taeniorhynchus
Agave sisalana fiber
Agrostis gigantea pollen
Agrostis stolonifera pollen
Ailanthus altissima pollen
Allenrolfea occidentalis pollen
Allspice
Almond
Alnus glutinosa
Alnus incana subsp. rugosa pollen
and 598 more with a free account

What you can answer from here — as of September 06, 2018

623DrugsEach linked to its full drug card

104Drug targetsEvery drug–target pair in the class, with bond type

12,321Marketed productsAcross the regions we cover, with dosage forms and routes

35Routes of administrationHow the drugs in this class are given

Which targets do Cell-mediated Immunity share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.